ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 114 filers reported holding ALBIREO PHARMA INC in Q3 2020. The put-call ratio across all filers is 7.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,066,988 | +61.8% | 78,029 | 0.0% | 0.28% | -11.0% |
| Q1 2020 | $1,277,335 | -35.6% | 78,029 | 0.0% | 0.32% | -9.1% |
| Q4 2019 | $1,983,497 | +450.1% | 78,029 | +332.8% | 0.35% | +212.5% |
| Q3 2019 | $360,580 | -38.0% | 18,029 | 0.0% | 0.11% | -31.3% |
| Q2 2019 | $581,255 | +0.1% | 18,029 | 0.0% | 0.16% | -3.6% |
| Q1 2019 | $580,714 | +31.3% | 18,029 | 0.0% | 0.17% | -29.3% |
| Q4 2018 | $442,251 | -25.6% | 18,029 | 0.0% | 0.24% | -8.4% |
| Q3 2018 | $594,236 | -7.2% | 18,029 | 0.0% | 0.26% | -10.9% |
| Q2 2018 | $640,030 | +9.0% | 18,029 | 0.0% | 0.29% | +7.3% |
| Q1 2018 | $587,205 | – | 18,029 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
| Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
| Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
| Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
| Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
| Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
| APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
| Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
| Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |